RENAISSANCE TECHNOLOGIES LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in DYN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,008,304

-$1,665,864 QoQ

Shares Held

360,572

-32.4% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#59

of 245 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. DYN ranks #60 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,008,304	360,572	-32.4%	Shares	Sole	2026-08-13
2026-03-31	$9,674,168	533,600	+13.4%	Shares	Sole	2026-05-14
2025-12-31	$9,205,816	470,645	+36.2%	Shares	Sole	2026-02-12
2025-09-30	$4,370,575	345,500	+174.2%	Shares	Sole	2025-11-13
2024-06-30	$4,446,540	126,000	+71.9%	Shares	Sole	2024-08-09
2023-03-31	$844,416	73,300	-31.9%	Shares	Sole	2023-05-12
2022-12-31	$1,248,243	107,700	+2.7%	Shares	Sole	2023-02-13
2022-09-30	$1,332,230	104,900	+15.0%	Shares	Sole	2022-11-14
2022-06-30	$626,544	91,200	+113.6%	Shares	Sole	2022-08-12
2022-03-31	$411,628	42,700	-37.7%	Shares	Sole	2022-05-13
2021-12-31	$814,465	68,500	-51.2%	Shares	Sole	2022-02-11
2021-09-30	$2,281,720	140,500	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.